ECSP993092A - HEPATITIS C INHIBITING TRIPEPTIDES - Google Patents

HEPATITIS C INHIBITING TRIPEPTIDES

Info

Publication number
ECSP993092A
ECSP993092A ECSP993092A ECSP993092A EC SP993092 A ECSP993092 A EC SP993092A EC SP993092 A ECSP993092 A EC SP993092A EC SP993092 A ECSP993092 A EC SP993092A
Authority
EC
Ecuador
Prior art keywords
formula
amido
alkyl
optionally substituted
lower alkyl
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Montse Llinas-Brunet
Murray D Bailey
Elise Ghiro
Anne-Marie Faucher
Marc Andre Poupart
Youla S Tsantrizos
Nathalie Goudreau
Teddy Halmos
Jean Rancourt
Dale R Cameron
Dominik M Wernic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993092 priority Critical patent/ECSP993092A/en
Publication of ECSP993092A publication Critical patent/ECSP993092A/en

Links

Abstract

Racematos, diastereoisómeros e isómeros ópticos de un compuesto de fórmula (I), (gráfico), en que B es H, un arilo C6 ó C10, arilalquilo C7-16; Het o (alquil inferior)-Het, todos ellos opcionalmente sustituidos con alquilo C1-6; alcoxi C1-6; alcanoilo C1-6; hidroxi, hidroxialquilo; halo; haloalquilo; nitro; ciano; cianoalquilo; amino opcionalmente sustituido con alquilo C1-6; amido; o (alquil inferior) amido; o B es un derivado de acilo de fórmula R4-C(O); un carboxilo de fórmula R4-O-C(O); un amido de fórmula R4-NH-C(O); un tioamido de fórmula R4-N(R5)-, C(S); o un sulfonilo de fórmula R4-SO2; R5 es H o alquilo C1-6; e Y es H o alquilo C1-6; R3 es alquilo C1-8 cicloalquilo C3-7 o alquilcicloalquilo C4-10, todos ellos opcionalmente sustituidos con hidroxi, alcoxi C1-6, tioalquilo C1-6, amido, (alquil Inferior) amido, arilo C6 ó C10 o arilalquilo C7-16; R2 es CH2-R20, NH-R20, O-R20 ó S-R20, en que R20 es un cicloalquilo C3-7 o (alquilcicloalquilo) C4-10 saturado o insaturado, estando todos ellos opcionalmente mono-, di o tri-sustituidos con R21, en la que los subtituyentes R1, R2, R3, A, X e Y tienen el significado indicativo, asi como a procedimientos para su preparación y a su uso como medicamentos, en especial como medicamentos para el taratmiento de enfermedades cardiocirulatorias.Racemates, diastereoisomers and optical isomers of a compound of formula (I), (graph), wherein B is H, a C6 or C10 aryl, C7-16 arylalkyl; Het or (lower alkyl) -Het, all optionally substituted with C1-6alkyl; C1-6 alkoxy; C1-6 alkanoyl; hydroxy, hydroxyalkyl; halo; haloalkyl; nitro; cyano; cyanoalkyl; amino optionally substituted with C1-6alkyl; amido; or (lower alkyl) amido; or B is an acyl derivative of formula R4-C (O); a carboxyl of formula R4-O-C (O); an amido of formula R4-NH-C (O); a thioamido of formula R4-N (R5) -, C (S); or a sulfonyl of formula R4-SO2; R5 is H or C1-6 alkyl; and Y is H or C1-6 alkyl; R3 is C1-8 alkyl C3-7 cycloalkyl or C4-10 alkylcycloalkyl, all optionally substituted with hydroxy, C1-6 alkoxy, thioalkyl C1-6, amido, (lower alkyl) amido, C6 or C10 aryl or C7-16 arylalkyl ; R2 is CH2-R20, NH-R20, O-R20 or S-R20, where R20 is a C3-7 cycloalkyl or C4-10 (alkylcycloalkyl) saturated or unsaturated, all of which are optionally mono-, di or tri-substituted with R21, in which the substituents R1, R2, R3, A, X and Y have the indicative meaning, as well as procedures for their preparation and their use as drugs, especially as drugs for the treatment of cardio-circulatory diseases.

ECSP993092 1999-08-10 1999-08-10 HEPATITIS C INHIBITING TRIPEPTIDES ECSP993092A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993092 ECSP993092A (en) 1999-08-10 1999-08-10 HEPATITIS C INHIBITING TRIPEPTIDES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993092 ECSP993092A (en) 1999-08-10 1999-08-10 HEPATITIS C INHIBITING TRIPEPTIDES

Publications (1)

Publication Number Publication Date
ECSP993092A true ECSP993092A (en) 1999-10-29

Family

ID=42044079

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993092 ECSP993092A (en) 1999-08-10 1999-08-10 HEPATITIS C INHIBITING TRIPEPTIDES

Country Status (1)

Country Link
EC (1) ECSP993092A (en)

Similar Documents

Publication Publication Date Title
AR020880A1 (en) HEPATITIS C INHIBITING PEPTIDES
AR002740A1 (en) COMPOUND DERIVED FROM ISOTIAZOLONE AND PHARMACEUTICAL FORMULATION WITH THE SAME.
ECSP066985A (en) DERIVATIVES OF PROLINA AND ITS USE AS INHIBITORS OF DIPEPTIDILPEPTIDASA-IV
UY28369A1 (en) THERAPEUTIC AGENTS
CY1106679T1 (en) AZADICYCLIC HETEROCYCLIC COMPOUNDS AS CANNABINOID RECEPTOR MODIFIERS
WO2003062259A3 (en) Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
PE20040636A1 (en) RIBOFURANOSYLCITIDINE ESTER OF 2'-C-METHYL-3'-O-L-VALINE
PA8592001A1 (en) HETEROAROMATIC GLOCOQUINASE ACTIVATORS OF SIX 5-SUBSTITUTED MEMBERS
GT200600398A (en) ISOINDOL-IMIDA COMPOUNDS AND COMPOSITIONS INCLUDING THEM AND METHODS FOR USE
ECSP056240A (en) PIRIDO DERIVATIVES [2,1-A] ISOQUINOLINE AS DPP-IV INHIBITORS
UY28150A1 (en) THERAPEUTIC AGENTS
GT200600161A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS
AR049125A1 (en) INHIBITING NITROGEN BICYCLE HYPERCYCLES OF THE AROMATASE.
BRPI0407922A (en) isoquinoline derivatives and methods of use of these
AR047085A1 (en) DERIVATIVES OF (3-OXO-3,4-DIHIDRO-QUINOXALINA-2-IL-AMINO) BENZAMIDE AND RELATED COMPOUNDS AS INHIBITORS OF GLUCOGENO FOSFORILASA FOR THE TREATMENT OF DIABETES AND OBESITY
AR056702A1 (en) NAFTILO DERIVATIVES INHIBITORS OF THE BETA-AMILOIDE AGREGATION
UY27018A1 (en) PIRIMIDINE DERIVATIVES
BR0010694A (en) Substituted benzoylisoxazoles
AR046874A1 (en) NEW METHODS
UY27651A1 (en) NEW COMPOSITIONS OF DRUGS THAT, TOGETHER WITH COLLINERIC AGENTS, CONTAIN HETEROCYCLIC COMPOUNDS
AR057816A1 (en) ORGANIC COMPOUNDS
ECSP993092A (en) HEPATITIS C INHIBITING TRIPEPTIDES
GT200200275A (en) ESTER DERIVATIVES OF PIRROLIDINE-2-CARBOXYL ACID
ATE479695T1 (en) SULFOPYRANOSYLACYLGLYCEROL DERIVATIVES FOR USE IN COMBINATION WITH RADIATION IN TUMOR RADIOTHERAPY
AR046673A1 (en) DIFENYLAMINE DERIVATIVES